Business Impact of the Prolonged and Renewed Spread of COVID-19
First written in FY2020. 6 of 13 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025ReframedAnnual report
「If a new infectious disease emerges and reaches a scale exceeding expectations, the results of our group may be affected by declining demand and loss of sales opportunities resulting from the downsizing, postponement or cancellation of various events and stagnation of corporate activity.」
The disclosure was reorganized from a focus on COVID-19 to infectious disease risks in general, including the simultaneous lockdown of multiple production sites. - FY2024-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company stated that there had been no significant changes to business and other risks. - FY2023-Q3SoftenedAnnual report
「In Wellness Products, following the reclassification of COVID-19 under the Infectious Diseases Control Law to Category 5, we decided to discontinue handling infectious disease prevention products.」
Following the reclassification of COVID-19 to Category 5 under the Infectious Diseases Control Law, the company discontinued its infectious disease prevention products and stated that the impact of the infectious disease on the business environment had diminished further. - FY2023-Q2SoftenedAnnual report
「During the six months ended the second quarter, restrictions on movement imposed due to COVID-19 were eased and socioeconomic activity moved toward normalization. However, the deterioration in the terms of trade due to soaring energy and raw-material prices caused by the situation between Russia and Ukraine and yen depreciation remained unresolved. Concerns also arose over the impact on the Japanese economy of a global economic downturn accompanying continued monetary tightening worldwide, and the outlook remained uncertain.」
The company described the easing of restrictions on activities and the normalization of social and economic activity, indicating that business-environment risks from the infectious disease had eased to some extent. However, the risk section stated that there had been no significant changes and that the situation would continue to be monitored closely. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no occurrences of matters relating to the business or accounting situation described in this quarterly report that could materially affect investors' decisions, nor any significant changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the impact of the spread of COVID-19 on our business.」
The company stated that there had been no significant changes to business and other risks and that it would continue to closely monitor the impact of COVID-19 on the business. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no occurrences of matters relating to the business or accounting situation described in this quarterly report that could materially affect investors' decisions, nor any significant changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the impact of the spread of COVID-19 on our business.」
The company stated that there had been no significant changes to business and other risks and that it would continue to closely monitor the impact of COVID-19 on the business. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no occurrences of matters relating to the business or accounting situation described in this quarterly report that could materially affect investors' decisions, nor any significant changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the impact of the spread of COVID-19 on our business.」
The company stated that there had been no significant changes to business and other risks and that it would continue to closely monitor the impact of the spread of the infectious disease. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no occurrences of matters relating to the business or accounting situation described in this quarterly report that could materially affect investors' decisions, nor any significant changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the impact of the spread of COVID-19 on our business.」
The company stated that there had been no significant changes to business and other risks and that it would continue to closely monitor the impact of the spread of the infectious disease on the business. - FY2021SoftenedAnnual report
「We believe that the impact of COVID-19 is subsiding as the number of new infections declines. However, if infections spread again on a scale exceeding expectations, the results of our group may be affected.」
Regarding infectious disease risk, the company indicated that new infections were declining and that the situation was moving toward containment, while maintaining the possibility of an impact if infections spread again. - FY2021-Q3WorsenedAnnual report
「During the cumulative third quarter under review, Japan's economy remained extremely uncertain, as COVID-19 shifted from a state of stagnation to expansion and, from January 2021 onward, states of emergency were declared intermittently and priority preventive measures were applied, mainly in major prefectures and urban areas.」
As infections spread again and states of emergency and priority preventive measures were applied intermittently, uncertainty over the outlook persisted and became more concrete. - FY2021-Q2WorsenedAnnual report
「During the cumulative second quarter under review, Japan's economy remained extremely uncertain, as COVID-19 shifted from a state of stagnation to expansion and a state of emergency was reissued in January, mainly in urban areas.」
The risk of prolonged and renewed spread became more concrete as infections spread again and a state of emergency was reissued, mainly in urban areas. - FY2021-Q1RestatedAnnual report
「We will continue to closely monitor the impact of the spread of COVID-19 on our business.」
Although stating that there had been no significant changes to business and other risks, the company noted that it would continue to closely monitor the impact of the spread of the infectious disease. - FY2020First statedAnnual report
「We have projected the impact on results for the fiscal year ending August 2021 based on the assumption that the impact of COVID-19 would subside from the latter half of the third quarter. However, if infections spread or continue for an extended period, the results of our group may be affected.」
The prolonged and renewed spread of the infectious disease, reissuance of a state of emergency, event cancellations, declining demand and loss of sales opportunities were identified as separate risks. Restrictions on economic activity due to the infectious disease have already occurred.